Nutrien Stock Forecast, Price & News

Nutrien's stock was trading at $32.00 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, NTR shares have increased by 67.0% and is now trading at $53.45.
View which stocks have been most impacted by COVID-19.

19 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Nutrien in the last twelve months. There are currently 1 sell rating, 6 hold ratings, 11 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" Nutrien stock.
View analyst ratings for Nutrien or view MarketBeat's top 5 stock picks.

Wall Street analysts have given Nutrien a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Nutrien wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

6,978 employees have rated Nutrien CEO Larry J. Merlo on Glassdoor.com. Larry J. Merlo has an approval rating of 37% among Nutrien's employees. This puts Larry J. Merlo in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

Nutrien is scheduled to release its next quarterly earnings announcement on Wednesday, February 17th 2021.
View our earnings forecast for Nutrien.

Nutrien will be holding an earnings conference call on Wednesday, February 17th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

Nutrien Ltd. (NYSE:NTR) posted its quarterly earnings results on Monday, November, 2nd. The company reported $0.23 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.07 by $0.16. The firm had revenue of $4.21 billion for the quarter, compared to analyst estimates of $3.83 billion. Nutrien had a return on equity of 4.19% and a net margin of 0.47%. The company's quarterly revenue was up .9% on a year-over-year basis. During the same period last year, the business posted $0.24 EPS.
View Nutrien's earnings history.

Nutrien announced a quarterly dividend on Thursday, December 10th. Shareholders of record on Thursday, December 31st will be paid a dividend of $0.346 per share on Thursday, January 14th. This represents a $1.38 dividend on an annualized basis and a dividend yield of 2.59%. The ex-dividend date of this dividend is Wednesday, December 30th.
View Nutrien's dividend history.

Nutrien pays an annual dividend of $1.80 per share and currently has a dividend yield of 3.37%. Nutrien does not yet have a strock track record of dividend growth. The dividend payout ratio of Nutrien is 82.95%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on EPS estimates, Nutrien will have a dividend payout ratio of 79.65% in the coming year. This indicates that Nutrien may not be able to sustain their current dividend.
View Nutrien's dividend history.

Nutrien issued an update on its FY 2020 After-Hours earnings guidance on Monday, November, 2nd. The company provided EPS guidance of 1.60-1.85 for the period.

19 brokerages have issued twelve-month price objectives for Nutrien's stock. Their forecasts range from $40.00 to $58.00. On average, they expect Nutrien's stock price to reach $49.00 in the next twelve months. This suggests that the stock has a possible downside of 8.3%.
View analysts' price targets for Nutrien or view Wall Street analyst' top-rated stocks.

Nutrien saw a decline in short interest in the month of December. As of December 31st, there was short interest totaling 5,300,000 shares, a decline of 20.2% from the December 15th total of 6,640,000 shares. Based on an average daily volume of 1,380,000 shares, the short-interest ratio is currently 3.8 days. Currently, 0.9% of the company's shares are sold short.
View Nutrien's Short Interest.

Some companies that are related to Nutrien include The Scotts Miracle-Gro (SMG), The Mosaic (MOS), CF Industries (CF), ICL Group (ICL), American Vanguard (AVD), Bioceres Crop Solutions (BIOX), Calyxt (CLXT), Marrone Bio Innovations (MBII), CVR Partners (UAN), Evogene (EVGN), Wynnstay Group Plc (WYN.L) (WYN), Eden Research plc (EDEN.L) (EDEN), China Green Agriculture (CGA), Bion Environmental Technologies (BNET) and SenesTech (SNES).
View all of NTR's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Nutrien investors own include AT&T (T), Pfizer (PFE), Johnson & Johnson (JNJ), General Electric (GE), Intel (INTC), Bank of America (BAC), CVS Health (CVS), AbbVie (ABBV), JPMorgan Chase & Co. (JPM) and Micron Technology (MU).

Nutrien trades on the New York Stock Exchange (NYSE) under the ticker symbol "NTR."

Nutrien's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Galibier Capital Management Ltd. (0.24%), Livingston Group Asset Management CO operating as Southport Capital Management (0.05%), Hexavest Inc. (0.04%), Signature Wealth Management Group (0.01%), Crossmark Global Holdings Inc. (0.01%) and Raymond James Trust N.A. (0.01%).

NTR stock was sold by a variety of institutional investors in the last quarter, including Hexavest Inc., Livingston Group Asset Management CO operating as Southport Capital Management, Addenda Capital Inc., DAVENPORT & Co LLC, Huntington National Bank, Investors Research Corp, Liberty One Investment Management LLC, and Cascade Investment Advisors Inc..

NTR stock was bought by a variety of institutional investors in the last quarter, including Galibier Capital Management Ltd., Kestra Advisory Services LLC, Signature Wealth Management Group, Raymond James Trust N.A., Pacifica Partners Inc., Fruth Investment Management, and Crossmark Global Holdings Inc..

Shares of NTR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of NTR stock can currently be purchased for approximately $53.45.

Nutrien has a market capitalization of $30.42 billion and generates $20.02 billion in revenue each year. The company earns $992 million in net income (profit) each year or $2.17 on an earnings per share basis. Nutrien employs 22,300 workers across the globe.

The official website for Nutrien is www.nutrien.com.

Nutrien's mailing address is SUITE 500 122 - 1ST AVENUE SOUTH, SASKATOON A9, S7K 7G3. The company can be reached via phone at 306-933-8500 or via email at [email protected]